Back
Status filter :


RESET SEARCH AND FILTERS
Musculoskeletal system
Musculoskeletal system / Pain and inflammation in musculoskeletal disorders
  aceclofenac Not approved for prescribing
  celecoxib Not approved for prescribing
  dexketoprofen Not approved for prescribing
  diclofenac potassium Not approved for prescribing
  diclofenac sodium Specialist knowledge/initiation
  Modified-release tablet
Dicloflex 75mg SR (Dexcel-Pharma Ltd) Not approved for prescribing
Dicloflex Retard (Dexcel-Pharma Ltd) Not approved for prescribing
Enstar XL (Ennogen Pharma Ltd) Not approved for prescribing
  Gastro-resistant tablet
Diclofenac sodium (Non-proprietary) Specialist knowledge/initiation
  Modified-release capsule
Diclomax Retard (Galen Ltd) Not approved for prescribing
Diclomax SR (Galen Ltd) Not approved for prescribing
Motifene (Glenwood GmbH) Not approved for prescribing
  Solution for injection
Akis (Flynn Pharma Ltd) Hospital only
Voltarol (Novartis Pharmaceuticals UK Ltd) Hospital only
  Suppository
Econac (Advanz Pharma) Specialist knowledge/initiation
Voltarol (Novartis Pharmaceuticals UK Ltd) Specialist knowledge/initiation
  diclofenac sodium with misoprostol Not approved for prescribing
  Gastro-resistant tablet
Arthrotec (Pfizer Ltd) Not approved for prescribing
  etodolac Not approved for prescribing
  Modified-release tablet
Etolyn (Viatris UK Healthcare Ltd) Not approved for prescribing
Etopan XL (Sun Pharmaceutical Industries Europe B.V.) Not approved for prescribing
Lodine SR (Almirall Ltd) Not approved for prescribing
  etoricoxib Specialist knowledge/initiation
  felbinac Not approved for prescribing
  flurbiprofen Not approved for prescribing
  Eye drops
Ocufen (AbbVie Ltd) Not approved for prescribing
  ibuprofen Joint formulary choice
  Orodispersible tablet
Nurofen Meltlets (Reckitt Benckiser Healthcare (UK) Ltd) Not approved for prescribing
  Modified-release tablet
Brufen Retard (Viatris UK Healthcare Ltd) Not approved for prescribing
  Modified-release capsule
Ibuprofen (Non-proprietary) Not approved for prescribing
  Effervescent granules
Brufen (Viatris UK Healthcare Ltd) Not approved for prescribing
  Oral suspension
Ibuprofen (Non-proprietary) Joint formulary choice
Brufen (Viatris UK Healthcare Ltd) Not approved for prescribing
Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) Not approved for prescribing
  Cutaneous gel
Ibuprofen (Non-proprietary) Joint formulary choice
  indometacin Joint formulary choice
  ketoprofen Not approved for prescribing
  Modified-release capsule
Larafen CR (Ennogen Pharma Ltd) Not approved for prescribing
Oruvail (Sanofi) Not approved for prescribing
  mefenamic acid Joint formulary choice
  Oral suspension
Mefenamic acid (Non-proprietary) Joint formulary choice
  meloxicam Not approved for prescribing
  Orodispersible tablet
Meloxicam (Non-proprietary) Not approved for prescribing
  nabumetone Not approved for prescribing
  naproxen Joint formulary choice
  Gastro-resistant tablet
Naproxen (Non-proprietary) Joint formulary choice
Naprosyn EC (Atnahs Pharma UK Ltd) Joint formulary choice
  Oral suspension
Naproxen (Non-proprietary) Joint formulary choice
  naproxen with esomeprazole Not approved for prescribing
  Modified-release tablet
Vimovo (Grunenthal Ltd) Not approved for prescribing
  piroxicam Joint formulary choice
Oral piroxicam is not approved for prescribing

Piroxicam capsules and oral dispersible tablets are not approved for prescribing.

Topical piroxicam can be prescribed for pain.  

  Orodispersible tablet
Feldene Melt (Pfizer Ltd) Not approved for prescribing
  sulindac Not approved for prescribing
  tenoxicam Not approved for prescribing
  tiaprofenic acid Not approved for prescribing
  tramadol with dexketoprofen Not approved for prescribing
Musculoskeletal system / Soft tissue and joint disorders
  AUTOLOGOUS CHONDROCYTE IMPLANTATION Non-formulary at HHFT and not suitable for primary care prescribing
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Musculoskeletal system / Local inflammation of joints and soft tissue
  dexamethasone Not approved for prescribing NICE TA229
NICE TA824
NICE TA460
  hydrocortisone Specialist knowledge/initiation
  Solution for injection
Hydrocortisone (Non-proprietary) Specialist knowledge/initiation
  methylprednisolone Specialist knowledge/initiation
  Suspension for injection
Depo-Medrone (Pfizer Ltd) Specialist knowledge/initiation
  methylprednisolone with lidocaine Not approved for prescribing
  Suspension for injection
Depo-Medrone with Lidocaine (Pfizer Ltd) Not approved for prescribing
  prednisolone Joint formulary choice
  Gastro-resistant tablet
Prednisolone (Non-proprietary) Not approved for prescribing
Dilacort (Crescent Pharma Ltd) Not approved for prescribing
  Oral solution
Prednisolone (Non-proprietary) Joint formulary choice
  triamcinolone acetonide Specialist knowledge/initiation
  Suspension for injection
Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) Specialist knowledge/initiation
Kenalog (Bristol-Myers Squibb Pharmaceuticals Ltd) Specialist knowledge/initiation
  triamcinolone hexacetonide Not approved for prescribing
  Suspension for injection
Triamcinolone hexacetonide (Non-proprietary) Not approved for prescribing
Musculoskeletal system / Soft tissue disorders
  hyaluronidase Non-formulary at HHFT and not suitable for primary care prescribing
  Powder for solution for injection
Hyaluronidase (Non-proprietary) Non-formulary at HHFT and not suitable for primary care prescribing
Musculoskeletal system / Hyperuricaemia and gout
  Lesinurad Not approved for prescribing
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  allopurinol Joint formulary choice
  canakinumab Not approved for prescribing
  colchicine Joint formulary choice
  diclofenac potassium Not approved for prescribing
  diclofenac sodium Specialist knowledge/initiation
  Modified-release tablet
Dicloflex 75mg SR (Dexcel-Pharma Ltd) Not approved for prescribing
Dicloflex Retard (Dexcel-Pharma Ltd) Not approved for prescribing
Enstar XL (Ennogen Pharma Ltd) Not approved for prescribing
  Gastro-resistant tablet
Diclofenac sodium (Non-proprietary) Specialist knowledge/initiation
  Modified-release capsule
Diclomax Retard (Galen Ltd) Not approved for prescribing
Diclomax SR (Galen Ltd) Not approved for prescribing
Motifene (Glenwood GmbH) Not approved for prescribing
  Suppository
Econac (Advanz Pharma) Specialist knowledge/initiation
Voltarol (Novartis Pharmaceuticals UK Ltd) Specialist knowledge/initiation
  etoricoxib Specialist knowledge/initiation
  febuxostat Specialist knowledge/initiation NICE TA164
  indometacin Joint formulary choice
  ketoprofen Not approved for prescribing
  Modified-release capsule
Larafen CR (Ennogen Pharma Ltd) Not approved for prescribing
Oruvail (Sanofi) Not approved for prescribing
  naproxen Joint formulary choice
  Gastro-resistant tablet
Naproxen (Non-proprietary) Joint formulary choice
Naprosyn EC (Atnahs Pharma UK Ltd) Joint formulary choice
  Oral suspension
Naproxen (Non-proprietary) Joint formulary choice
  naproxen with esomeprazole Not approved for prescribing
  Modified-release tablet
Vimovo (Grunenthal Ltd) Not approved for prescribing
  sulindac Not approved for prescribing
Musculoskeletal system / Arthritis
  abatacept Hospital only NICE TA195
NICE TA375
NICE TA715
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for injection
Orencia (Bristol-Myers Squibb Pharmaceuticals Ltd, Imported (Germany)) Hospital only
Orencia ClickJect (Bristol-Myers Squibb Pharmaceuticals Ltd) Hospital only
  aceclofenac Not approved for prescribing
  adalimumab Hospital only NICE TA187
NICE TA329
NICE TA199
NICE TA195
NICE TA375
NICE TA715
NICE TA383
NICE TA392
NICE TA146
NICE TA460
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

Where negative or terminated NICE Technology Appraisal(s) apply to this medicine

This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use.

  Solution for injection
Humira (AbbVie Ltd) Hospital only
ADALIMUMAB

Dose escalation of Adalimumab is approved for Crohn's disease and ulcerative colitis

  anakinra Hospital only NICE TA685
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for injection
Kineret (Swedish Orphan Biovitrum Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  apremilast Hospital only NICE TA433
NICE TA419
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  azathioprine Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  baricitinib Hospital only NICE TA466
NICE TA681
NICE TA926
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  bimekizumab Hospital only NICE TA723
NICE TA916
NICE TA918
  Solution for injection
Bimzelx (UCB Pharma Ltd) Hospital only
  capsaicin Not approved for prescribing
  celecoxib Not approved for prescribing
  certolizumab pegol Hospital only NICE TA375
NICE TA383
NICE TA415
NICE TA445
NICE TA574
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for injection
Cimzia (UCB Pharma Ltd) Hospital only
  chloroquine Hospital only
Prescribing of chloroquine for travelling purposes

Chloroquine for malaria prophylaxis should not be issued on an NHS prescription. Patients should be prescribed this on a private prescription for travelling purposes. 

  Oral solution
Malarivon (Wallace Manufacturing Chemists Ltd) Hospital only
  ciclosporin Shared care guideline NICE TA369
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Oral solution
Neoral (Novartis Pharmaceuticals UK Ltd) Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

Sandimmun (Novartis Pharmaceuticals UK Ltd) Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Solution for infusion
Sandimmun (Novartis Pharmaceuticals UK Ltd) Hospital only
  cyclophosphamide Hospital only
  Powder for solution for injection
Cyclophosphamide (Non-proprietary) Hospital only
  diclofenac potassium Not approved for prescribing
  diclofenac sodium Specialist knowledge/initiation
  Modified-release tablet
Dicloflex 75mg SR (Dexcel-Pharma Ltd) Not approved for prescribing
Dicloflex Retard (Dexcel-Pharma Ltd) Not approved for prescribing
Enstar XL (Ennogen Pharma Ltd) Not approved for prescribing
  Gastro-resistant tablet
Diclofenac sodium (Non-proprietary) Specialist knowledge/initiation
  Modified-release capsule
Diclomax Retard (Galen Ltd) Not approved for prescribing
Diclomax SR (Galen Ltd) Not approved for prescribing
Motifene (Glenwood GmbH) Not approved for prescribing
  Suppository
Econac (Advanz Pharma) Specialist knowledge/initiation
Voltarol (Novartis Pharmaceuticals UK Ltd) Specialist knowledge/initiation
  etanercept Hospital only NICE TA103
NICE TA195
NICE TA375
NICE TA715
NICE TA199
NICE TA383
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

Biosimilar preparation is available for this

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

  Solution for injection
Benepali (Biogen Idec Ltd) Hospital only
Biosimilar preparation is available for this

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

Enbrel (Pfizer Ltd) Hospital only
Biosimilar preparation is available for this

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

Enbrel MyClic (Pfizer Ltd) Hospital only
Biosimilar preparation is available for this

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

Erelzi (Sandoz Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Biosimilar preparation is available for this

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

  Powder and solvent for solution for injection
Enbrel (Pfizer Ltd) Hospital only
Biosimilar preparation is available for this

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

  etodolac Not approved for prescribing
  Modified-release tablet
Etolyn (Viatris UK Healthcare Ltd) Not approved for prescribing
Etopan XL (Sun Pharmaceutical Industries Europe B.V.) Not approved for prescribing
Lodine SR (Almirall Ltd) Not approved for prescribing
  etoricoxib Specialist knowledge/initiation
  filgotinib Hospital only NICE TA676
NICE TA792
Where positive NICE Technology Appraisal(s) apply to this medicine

The Joint Prescribing Group (JPG) agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Oral tablet
Jyseleca (Galapagos Biotech Ltd) Hospital only
  flurbiprofen Not approved for prescribing
  Eye drops
Ocufen (AbbVie Ltd) Not approved for prescribing
  glucosamine Not approved for prescribing
  golimumab Hospital only NICE TA220
NICE TA375
NICE TA225
NICE TA383
NICE TA497
NICE TA329
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for injection
Simponi (Merck Sharp & Dohme (UK) Ltd) Hospital only
  guselkumab Hospital only NICE TA521
NICE TA815
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Tremfya (Janssen-Cilag Ltd) Hospital only
  hydroxychloroquine sulfate Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  ibuprofen Joint formulary choice
  Orodispersible tablet
Nurofen Meltlets (Reckitt Benckiser Healthcare (UK) Ltd) Not approved for prescribing
  Modified-release tablet
Brufen Retard (Viatris UK Healthcare Ltd) Not approved for prescribing
  Modified-release capsule
Ibuprofen (Non-proprietary) Not approved for prescribing
  Effervescent granules
Brufen (Viatris UK Healthcare Ltd) Not approved for prescribing
  Oral suspension
Ibuprofen (Non-proprietary) Joint formulary choice
Brufen (Viatris UK Healthcare Ltd) Not approved for prescribing
Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) Not approved for prescribing
  indometacin Joint formulary choice
  infliximab Hospital only NICE TA134
NICE TA195
NICE TA375
NICE TA715
NICE TA199
NICE TA187
NICE TA163
NICE TA329
NICE TA383
Biosimilar

Remsima® (biosimilar infliximab) is the formulary choice brand for infliximab.

Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for injection
Remsima (Celltrion Healthcare UK Ltd) Hospital only
  ixekizumab Hospital only NICE TA442
NICE TA537
NICE TA718
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for injection
Taltz (Eli Lilly and Company Ltd) Hospital only
  ketoprofen Not approved for prescribing
  Modified-release capsule
Larafen CR (Ennogen Pharma Ltd) Not approved for prescribing
Oruvail (Sanofi) Not approved for prescribing
  leflunomide Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  mefenamic acid Joint formulary choice
  Oral suspension
Mefenamic acid (Non-proprietary) Joint formulary choice
  meloxicam Not approved for prescribing
  Orodispersible tablet
Meloxicam (Non-proprietary) Not approved for prescribing
  methotrexate Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Oral solution
Methotrexate (Non-proprietary) Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Solution for injection
Methotrexate (Non-proprietary) Hospital only
Metoject PEN (medac UK) Hospital only
Nordimet (Nordic Pharma Ltd) Hospital only
Zlatal (Nordic Pharma Ltd) Hospital only
  Solution for infusion
Methotrexate (Non-proprietary) Hospital only
  nabumetone Not approved for prescribing
  naproxen Joint formulary choice
  Gastro-resistant tablet
Naproxen (Non-proprietary) Joint formulary choice
Naprosyn EC (Atnahs Pharma UK Ltd) Joint formulary choice
  Oral suspension
Naproxen (Non-proprietary) Joint formulary choice
  penicillamine Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  piroxicam Joint formulary choice
Oral piroxicam is not approved for prescribing

Piroxicam capsules and oral dispersible tablets are not approved for prescribing.

Topical piroxicam can be prescribed for pain.  

  Orodispersible tablet
Feldene Melt (Pfizer Ltd) Not approved for prescribing
  risankizumab Hospital only NICE TA596
NICE TA803
NICE TA888
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for injection
Skyrizi (AbbVie Ltd) Hospital only
  rituximab Hospital only NICE TA308
NICE TA195
NICE TA243
NICE TA137
NICE TA193
NICE TA226
NICE TA174
NICE TA359
NICE TA561
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for infusion
MabThera (Roche Products Ltd) Hospital only
Rixathon (Sandoz Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Truxima (Celltrion Healthcare UK Ltd) Hospital only
  sarilumab Hospital only NICE TA485
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for injection
Kevzara (Sanofi) Hospital only
  secukinumab Hospital only NICE TA350
NICE TA407
NICE TA719
NICE TA445
NICE TA935
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for injection
Cosentyx (Novartis Pharmaceuticals UK Ltd) Hospital only
  sulfasalazine Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Gastro-resistant tablet
Sulfasalazine (Non-proprietary) Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

Salazopyrin EN (Pfizer Ltd) Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Oral suspension
Sulfasalazine (Non-proprietary) Shared care guideline
A formal Shared Care Guideline (SCG) may be available

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

  Suppository
Salazopyrin (Pfizer Ltd) Not approved for prescribing
  sulindac Not approved for prescribing
  tenoxicam Not approved for prescribing
  tiaprofenic acid Not approved for prescribing
  tocilizumab Hospital only NICE TA375
NICE TA247
NICE TA518
NICE TA878
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

NICE TA518 - Tocilizumab for the treatment of Giant Cell Arteritis in adults

Non-formulary at HUHFT. Hospital only for providers that have this on their formulary

The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE TA518.

 

  Solution for injection
RoActemra (Roche Products Ltd) Hospital only
  Solution for infusion
RoActemra (Roche Products Ltd) Hospital only
  tofacitinib Hospital only NICE TA480
NICE TA543
NICE TA920
NICE TA547
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Modified-release tablet
Xeljanz (Pfizer Ltd) Hospital only
  Oral tablet
Xeljanz (Pfizer Ltd) Hospital only
  upadacitinib Hospital only NICE TA665
NICE TA744
NICE TA768
NICE TA829
NICE TA861
NICE TA814
NICE TA856
NICE TA905
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Modified-release tablet
Rinvoq (AbbVie Ltd) Hospital only
  ustekinumab Hospital only NICE TA180
NICE TA340
NICE TA456
NICE TA633
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Solution for injection
Stelara (Janssen-Cilag Ltd) Hospital only
  Solution for infusion
Stelara (Janssen-Cilag Ltd) Hospital only
Musculoskeletal system / Neuromuscular disorders
  riluzole Shared care guideline NICE TA20
Where positive NICE Technology Appraisal(s) apply to this medicine

This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s).

  Oral suspension
Teglutik (Martindale Pharmaceuticals Ltd) Shared care guideline
Musculoskeletal system / Muscular dystrophy
  ataluren Non-formulary at HHFT and not suitable for primary care prescribing NICE HST22
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  nusinersen Non-formulary at HHFT and not suitable for primary care prescribing NICE TA588
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Solution for injection
Spinraza (Biogen Idec Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
  risdiplam Non-formulary at HHFT and not suitable for primary care prescribing NICE TA755
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

  Oral solution
Evrysdi (Roche Products Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Musculoskeletal system / Myasthenia gravis and Lambert-Eaton myasthenic syndrome
  amifampridine Non-formulary at HHFT and not suitable for primary care prescribing
  neostigmine Not approved for prescribing
  pyridostigmine bromide Not approved for prescribing
Musculoskeletal system / Nocturnal leg cramps
  quinine Joint formulary choice
Musculoskeletal system / Myotonic disorders
  mexiletine Non-formulary at HHFT and not suitable for primary care prescribing NICE TA748
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service

This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service.

Musculoskeletal system / Spasticity
  baclofen Specialist knowledge/initiation
Injection/infusion formulations

The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing).

  Oral solution
Baclofen (Non-proprietary) Specialist knowledge/initiation
Lioresal (Novartis Pharmaceuticals UK Ltd) Specialist knowledge/initiation
Lyflex (Rosemont Pharmaceuticals Ltd) Specialist knowledge/initiation
  Solution for injection
Baclofen (Non-proprietary) Hospital only
Lioresal (Novartis Pharmaceuticals UK Ltd) Hospital only
  Solution for infusion
Baclofen (Non-proprietary) Hospital only
Lioresal (Novartis Pharmaceuticals UK Ltd) Hospital only
  cannabis extract Non-formulary at HHFT and not suitable for primary care prescribing
Shared Care prescribing for patients initiated on treatment by the National Hospital for Neurology and Neurosurgery

NICE NG144 recommends Sativex® for severe treatment refractory multiple sclerosis related spasticity, initiated by a spasticity specialist which may be continued under a shared care agreement by non-specialists in primary care. This service is not provided at Homerton therefore it has a hospital only status, but if your patient has been referred to the National Hospital for Neurology and Neurosurgery (NHNN) there is an approved Shared Care Guideline to support the transfer of prescribing of Sativex® to primary care. 

  Spray
Sativex (GW Pharma Ltd) Non-formulary at HHFT and not suitable for primary care prescribing
Shared Care prescribing for patients initiated on treatment by the National Hospital for Neurology and Neurosurgery

NICE NG144 recommends Sativex® for severe treatment refractory multiple sclerosis related spasticity, initiated by a spasticity specialist which may be continued under a shared care agreement by non-specialists in primary care. This service is not provided at Homerton therefore it has a hospital only status, but if your patient has been referred to the National Hospital for Neurology and Neurosurgery (NHNN) there is an approved Shared Care Guideline to support the transfer of prescribing of Sativex® to primary care. 

  dantrolene sodium Specialist knowledge/initiation
Injection/infusion formulations

The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing).

  Powder for solution for injection
Dantrium (Forum Health Products Ltd) Hospital only
  diazepam Joint formulary choice
Injection/infusion formulations

The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing).

  Oral suspension
Diazepam (Non-proprietary) Joint formulary choice
  Oral solution
Diazepam (Non-proprietary) Joint formulary choice
  methocarbamol Not approved for prescribing
  tizanidine Not approved for prescribing